Circulating intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in patients with type 2 diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 46, Issue 2, 1999, Pages 143-148

  Kado, Seijiro ^a   Nagata, Naokazu ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Diabetes mellitus; E selectin; Intercellular adhesion molecule 1; Vascular cell adhesion molecule 1

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEMOGLOBIN A1C; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; AGING; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; E-SELECTIN; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; REFERENCE VALUES; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032736216     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00083-2     Document Type: Article

References (20)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
2. Springer T.A., Dustin M.L. Lymphocyte function associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J. Cell Biol. 107:1988;321-331.
3. Osborn L., Hession C., Tizard R. et al. Direct expression cloning of vascular adhesion molecule 1, a cytokine induced endothelial protein that binds to lymphocytes. Cell. 59:1989;1203-1211.
4. Bevilacqua M.P., Stengelin S., Gimbrone M.A. Endothelial leukocyte adhesion molecule-1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science. 243:1989;1160-1165.
5. Newman P.J., Berndt M.C., Gorski J. et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science. 247:1990;1219-1222.
6. Poston R.N., Haskard D.O., Coucher J.R., Gall N.P., Johnson-Tidey R.P. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am. J. Pathol. 140:1992;665-673.
7. Printseva O.Y., Peclo M.M., Gown A.M. Various cell types in human atherosclerotic lesions express ICAM-1. Further immunohistochemical and immunochemical studies employing monoclonal antibody 10F3. Am. J. Pathol. 140:1992;889-896.
8. Richardson M., Hadcock S.J., Dereske M., Cybulsky M. Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipidemic and hyperlipidemic diabetic rabbits. Arterioscler. Thromb. 14:1994;760-769.
9. Szekanecz Z., Shah M.R., Pearce W.H., Roch A.E. Intercellular adhesion molecule-1 (ICAM-1) expression and soluble ICAM-1 (sICAM-l) production by cytokine-activated human aortic endothelial cells: a possible role for ICAM-1 and sICAM-1 in atherosclerotic aortic aneurysms. Clin. Exp. Immunol. 98:1994;337-343.
10. Gearing A.J.H., Newman W. Circulating adhesion molecules in disease. Immunol. Today. 14:1993;506-512.
11. Rothlein R., Mainolfi E.A., Czajkowski M., Marlin S.D. A form of circulating ICAM-1 in human serum. J. Immunol. 147:1991;3788-3793.
12. Taki H., Rashiwagi A., Tanaka Y., Horiike R. Expression of intercellular adhesion molecule 1 (ICAM-1) via an osmotic effect in human umbilical vein endothelial cells exposed to high glucose medium. Life Sci. 58:1996;1713-1721.
13. Fasching P., Waldhausl W., Wagner O.F. Elevated circulating adhesion molecules in NIDDM: potential mediators in diabetic macroangiopathy. Diabetologia. 39:1996;1242-1244. Letter.
14. Peter R., Nowroth P., Conradt C. et al. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler. Thromb. Vasc. Biol. 17:1997;505-512.
15. Otsuki M., Hashimoto R., Morimoto Y., Rishimoto T., Rasayama S. Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients. Diabetes. 46:1997;2096-2101.
16. Rawamura T., Umemura T., Ranai A. et al. The incidence and characteristics of silent cerebral infarction in elderly diabetic patients: association with serum-soluble adhesion molecules. Diabetologia. 41:1998;911-917.
17. Baumgartner-Parzer S.M., Wagner L., Pettermann M., Gessl A., Waldhausl W. Modulation by high glucose of adhesion molecule expression in cultured endothelial cells. Diabetologia. 38:1995;1367-1370.
18. Cominacini L., Pasini A.F., Garbin U. et al. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia. 38:1995;1122-1124.
19. Waller B.R.F., Palumbo P.J., Roberts W.C. Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years. Am. J. Med. 69:1980;498-506.
20. Christensen T., Neubauer B. Increased arterial wall stiffness and thickness in medium sized arteries in patients with insulin dependent diabetes mellitus. Acta Radiol. Diagn. 29:1988;299-302.